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Abstract 
  
Cu
+
-ATPases are involved in efflux of copper from the cytoplasm. Under physiological 
conditions these ATPases receive the metal from a specific metallochaperone. We hypothesize 
that the specificity of the interaction is provided by electrostatic interactions between the 
transporter and its chaperone. If there are charged or polar amino acids that lie on the rim of the 
chaperone around the copper binding residues, they could potentially interact with the transporter 
during copper delivery. To test this hypothesis, I used a model system with a Cu
+
 chaperone 
(Archaeoglobus fulgidus CopZ) and analyzed the effects on the ATPase activity of its respective 
transporter (CopA). I created mutants in CopZ that replaced charged residues (Asp, Ser, Thr, and 
Tyr) and measured the effect on the activation of CopA by CopZ. If the residues were involved 
in copper delivery, there would be an increase in the K½ or a decrease in the Vmax of the ATPases 
with the mutant CopZ molecules. There appears to be no significant effect on activity when the 
Asp is mutated to either an Ala or a Lys. 
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Introduction 
In small amounts, heavy metals serve important roles in living organisms such as 
respiration, collagen maturation, and pigmentation (1). In contrast, excess free metal in the cell 
leads to free radicals and irreversible binding to proteins (2). For this reason, mechanisms to 
control cellular concentrations of metal are necessary. These mechanisms include chelating 
agents, chaperones, and transport (efflux and influx) proteins which have a high affinity for the 
metals (1).  
P-type ATPases are a family of membrane proteins characterized by the E1/E2 Albers-
Post catalytic cycle (Fig. 1, (3)).  In the cytoplasmic side of the membrane, ATP binds the ATP 
binding domain (ATP-BD) and the metal binds to the transmembrane metal binding sites (TM-
MBS) with high affinity in the E1 conformation (step 4). After ATP phosphorylation, the 
enzyme changes conformation and the metal is not accessible from the cytoplasm (step 1). Next, 
the metal leaves the enzyme which is in the E2P conformation (step 2). The Pi is released from 
the enzyme to yield the E2 conformation (step 3). The enzyme then returns to the E1 
conformation in the presence of ATP and Cu
+
 (3). 
 
Figure 1. P1B-ATPases catalytic cycle. E1, E1P,  
E2, and E2P are the four main conformations 
that the enzyme can have. Mn+ is the metal 
transported by the enzyme and n is the 
stoichiometry of the metal being transported. 
Mn+cyt and Mn
+
out are the cytoplasmic or 
extracellular locations of the metal (3). 
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P1B-type ATPases are a subfamily of P-type ATPases that transport heavy metals, 
including Cu
+
, Cu
2+
, Zn
2+
, and Co
2+
 across the membrane out of the cytoplasm (4). These 
proteins are found in most organisms (4). Characteristics of P1B-ATPases include 8 or 6 
transmembrane segments (TMs), a regulatory cytoplasmic metal binding domain (MBD), an 
ATP binding domain, and a signature metal-binding sequence in the TMs (3).  
CopA has 8 TMs with cytoplasmic loops. Within the TMs, there are two TM-MBS. 
These sites consist of conserved residues that coordinate and move the metal across the 
membrane (5,6). In the sixth TM, the conserved sequence is CPC. In the seventh TM, Asn and 
Tyr are conserved. Met and Ser are conserved within the eighth TM (Fig. 2, (4)).  
Between TM 6 and 7, there is a large cytoplasmic loop that has a conserved DKTGT 
sequence. This loop is the ATP-BD and consists of the nucleotide binding (N) and the 
phosphorylation (P) domains. The ATP binding domain has a high affinity for ATP, but is much 
lower in the E2 conformation. The DKTGT is located in the P- domain, where the Asp becomes 
phosphorylated when the ATP is used. There is a smaller loop between helix 4 and 5 which is the 
actuator (A) domain (3). 
 
Figure 2. Diagram of CopA, showing the 8 TMs. Below 
the TMs, crystal structures obtained from the Protein Data 
Bank (PDB) are shown of the soluble A-domain (PDB ID 
code 2HC8), and the ATP-BD (PDB ID code 2B8E). The 
N- and C- terminal metal binding domain (N-, C- MBD) 
crystal structures are homology models based on the 
fourth N-MBD Menkes protein (PDB ID code 1AW0) and 
Bacillus subtilis CopZ (PDB ID code 1K0V). The 
conserved amino acids in TM 6 – 8 that make up the TM-
MBS are also shown. The CopZ protein shown includes 
the N-domain structure (PDB ID code 2HU9) and a C-
domain homology model based on Enterococcus hirae 
CopZ (PDB ID code 1CPZ).The green arrow indicates the 
delivery path WT CopZ takes  (7).   
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CopA has cytoplasmic N- and C-terminal MBDs. These have a conserved CXXC metal 
binding sequence (8). A proposed mechanism is that in the absence of copper, the metal binding 
domains bind to the ATP-BD and prevent copper transport. When copper binds the MBDs, it 
detaches and allows the enzyme to transport copper (3).    
Humans have two P1B-Cu
+
-ATPases that are important in transporting copper out of the 
cell, ATP7A and ATP7B (9). Mutations in these proteins leads to Menkes and Wilson’s diseases 
(9). An analog of these proteins is Archaeoglobus fulgidus CopA which transports Cu
+
 (11).  
Copper cannot be free inside the cell because it is highly toxic (7). Therefore, most of the 
copper is complexed in a metallochaperone. CopZ is a Cu
+
 chaperone in A. fulgidus (12) which 
delivers copper to CopA in vitro (7). CopZ is 23 kDa (29.8 kDa with a His tag) and has two 
domains, the N- and C- domains. It binds 2 copper ions, 1 in each domain. The N-domain is a 
unique domain compared to other Cu
+
 chaperones. It is 14 kDa large and has no known function, 
however, it can reduce Cu(II) to Cu(I). There is a [2Fe-2S] cluster and a mononuclear zinc site 
(12). The C-domain is 9 kDa and has orthologues in many organisms (13). This domain contains 
two cysteines at amino acids 149 and 152 which coordinate the copper cation and has the 
characteristic CXXC metal binding sequence (13).  
CopZ can deliver Cu
+
 to the N- and C- MBD (6). However, the MBDs are not able to 
activate CopA. CopA without the N- and C- MBDs has the same Vmax as WT CopA which 
supports the hypothesis of the domains having a regulatory role.  
The objectives of this project were to find and mutate residues in CopZ that potentially 
participate in the interaction of CopZ with CopA when delivering copper and to observe the 
effect of these mutants on the ATPase activity of CopA. The mutations may change the affinity 
of CopZ for CopA, so the effects being looked at are changes in the Vmax and the K½ . 
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Materials and Methods 
Homology Modeling of Ct-CopZ: A suitable template for homology modeling of Ct-CopZ, the 
HMA domain of the copper chaperone for Homo sapiens superoxide dismutase (2CRL), was 
identified by performing a Fasta search (14) in the Protein Data Bank repository of protein 
structures. Ct-CopZ structures were modeled using SWISSMODEL (15), (16) and were 
visualized with PyMol (Delano Scientific). Electrostatic models were obtained using the APBS 
plugin for PyMol (17). 
 
CopZ and ΔN,C-CopA Cloning: The A. fulgidus CopA construct was previously made by cloning 
the CopA cDNA into a pBAD/Topo vector (11) and transformed into E. coli Top10 cells 
(Invitrogen). The ΔN,C-CopA construct (CopA with the N- and C-metal binding domains 
absent) was made by carrying out a Polymerase Chain Reaction (PCR) with primers at Gly
80
 and 
Gly
736
 using WT CopA as a template (7). To create the CopZ mutants, a pBAD/Topo vector 
(Invitrogen) containing CopZ cDNA was used as a template. Site directed mutagenesis was 
performed using PCR with primers (Sigma Genosys) designed to introduce mutations and a 
novel restriction site (Table 1). These mutations were T148A, S154A, D173A, D173K, and 
Y197A. To create the T148A, D173A, and Y197A mutants, the respective mutant primers (both 
5’ to 3’ and 3’ to 5’) were used to amplify the full CopZ/pBAD vector. PCRs were performed in 
a 50 µl reaction containing 5 mM of each primer, 5 mM dNTP, 1x red Taq buffer (Sigma), 1 µL 
red Taq polymerase (Sigma), and 20 ng template DNA in water. Regular Taq polymerase and 
Taq buffer (Sigma) were used if screening. The temperature conditions for all PCRs were: 
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1. 95 °C 5 min 
2. 95 °C 30 sec 
3. 55 °C 30 sec 
4. 72 °C 6 min 
5. 35 cycles to step 2 
6. 72 °C 7 min 
7. 4 °C 24 h 
Methylated bacterial template DNA was digested by incubating 1 µl DpnI with 35 µl of PCR 
product at 37 °C for 1 h and was then gel purified (Qiagen). The purified DNA was then 
transformed as described below. The D173K mutant was made using the megaprimer method 
(18). This involved 2 PCR steps. In the first step, the primers used were 5’ D173K and 3’ CopZ. 
This created the 3’ megaprimer, which was gel purified (Qiagen). Next, the 3’ megaprimer was 
used with 5’ CopZ primer to create the full length CopZ sequence. The amplicon DNA was A-
tailed by adding 25 µl DNA to a buffer containing 1X Taq polymerase buffer, 0.3 µM dATP, and 
1 µl Taq polymerase (Sigma) and incubated at 72 °C for 15 min. The A-tailed DNA was gel 
purified and then ligated into the pBAD/Topo vector (Invitrogen). This vector encodes an 
ampicillin resistance gene, is under the control of an arabinose inducible promoter, and 
introduces a (His)6 tag at the C-terminus of CopZ. CopZ cDNA in the pBAD/Topo vector was 
gel purified (Qiagen) to prevent any contaminant (not CopZ) DNA from entering the bacteria. 
The vector was transformed into Top10 Competent E. coli cells (Invitrogen). Only the bacteria 
transformed by the pBAD/Topo vector grew on a 2x YT + ampicillin (16 g/l tryptone, 10 g/l 
yeast extract, 5 g/l NaCl, 100 µg/ml ampicillin, and 2% agar) plate. The plates were grown 
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overnight at 37 °C. Colonies were screened by taking them with a pipette tip and agitating the 
bacteria in the PCR mix. Primers used in the PCR were 5’ CopZ and 3’ pBAD (Table 1) to check 
for correct orientation in the vector. A restriction digestion was performed with 8 µl of amplicon 
DNA from the PCR, 1 µl unique restriction enzyme (Table 1), and 1 µl appropriate buffer. The 
solution was incubated at 37 °C for 1 h. An agarose gel was run with the undigested amplicon 
DNA next to the digested DNA. Full sequence confirmation was obtained by sending vector 
DNA containing mutant CopZ to be sequenced by Macrogen.  
 
Table 1. Sequences of primers used to introduce mutations in CopZ DNA.  
The underlined letters are the changed nucleotides. The bold letters are the  
restriction site. 
 
Name 5' to 3' Sequence Restriction Enzyme 
T148A GACGGTCTCGCATGCATGGGG SphI 
S154A GGGGTGTGTTGCAGCTGTAAAG PvuII 
D173A ATTGGGCTGGCCCGGGCTGTT SmaI 
D173K ATTGGGCTTAAGAGGGCTGTT AflII 
Y197A GGAGCAGGCGCCTCTGCACGG NarI 
5’CopZ ATGATGCGATGCCCAGAATG N/A 
3’ CopZ TCTCTTTCAAGCCGTGCAGA N/A 
3’ pBAD GATTTAATCTGTATCAGGCT N/A 
 
Protein Expression in E. coli: The bacteria was grown in 2x YT media (16 g/l tryptone, 10 g/l 
yeast extract, and 5 g/l NaCl) with 100 µg/ml ampicillin at 37 °C until an OD600=0.6, when they 
were induced with 0.02% L-arabinose. The cells were harvested 3 h after induction, washed in 
buffer containing 25 mM Tris-HCl (pH 7.0) and 100 mM KCl, and stored at -80 °C.  
 
Protein Purification: Cells containing overexpressed protein were resuspended in buffer 
containing 25 mM Tris, pH 7.0, 100 mM sucrose, and 1 mM phenyl methyl sulfonyl fluoride 
(PMSF). They were lysed by passing through a French Press at 20,000 p.s.i. three times.  The 
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lysate was centrifuged at 9,000 rpm for 30 min. Supernatant of ΔN,C-CopA preparations was 
centrifuged at 33,000 rpm for 1 h. The pellet was resuspended in buffer B (25 mM Tris, pH 8.0, 
100 mM sucrose, 500 mM NaCl, 1 mM PMSF) and homogenized using a hand homogenizer. 
The homogenized membranes were solubilized by diluting to 3 mg/ml protein in buffer B and 
adding 0.75% n-Dodecyl-ß-maltoside (DDM) dropwise. This solution was stirred for 1 h at 4 C. 
Unsolubilized membrane was removed by centrifuging for 1 h at 33,000 rpm. The supernatant 
was incubated with Ni
2+
-nitrilotriacetic acid (Ni-NTA) resin for 1 h at 4 C. The solution was 
passed through a column and washed with 10 ml buffer B with 5 mM imidazole. The resin was 
washed a second time with buffer B with 20 mM imidazole and eluted with 10 ml buffer B with 
150 mM imidazole. The elution was concentrated using a 30 kDa centrifuge filter. Imidazole was 
removed by washing with buffer containing 25 mM Tris, pH 8.0, 100 mM sucrose, 50 mM NaCl, 
0.01% DDM, 1 mM dithiothreitol (DTT). When purifying CopZ, the steps were the same as 
above until the supernatant from the 30 min, 9,000 rpm centrifuge was passed through the Ni-
NTA column as above. CopZ protein was concentrated using a 10 kDa centrifuge filter. 
Imidazole was removed using the same buffer as above without DDM. Protein was stored at        
-80 C after adding 10% glycerol. Protein concentrations were determined by the method 
described by Bradford (19). 
 
Dot Blot to Confirm Expression: Aliquots (2 ml) of bacteria were collected and pelleted before 
induction and 3 h post induction to check expression levels of the mutants. Pellets were 
resuspended in 50 µl water and lysed using a sonicator at 40 watts for 30 sec. SDS was added to 
a concentration of 0.1% and the samples were boiled for 5 min. The protein in the sample was 
quantified. Cell lysate was pipetted onto a nitrocellulose membrane; 5 µg uninduced, 5 and 10 
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µg induced, 10 µg BSA (negative control), and 5 µg CopA with a His tag as a positive control. 
The membrane was allowed to dry. It was then rinsed with buffer 229 (50 mM Tris pH 7.4 and 
0.2 M NaCl), then blocked with buffer 229 with 5% nonfat dry milk (blocking solution) for 20 
min with horizontal rocking. Blocking solution and a 1:1000 dilution of Anti-His primary 
antibody (Santacruz) was added and rocked overnight at 4 °C. The antibody was poured off and 
washed with buffer 229 with 0.05% Tween 20 twice, then twice with 5 min rocking. There was 
one last wash with just buffer 229 for 5 min, then a 1:1000 dilution of the secondary antibody 
(Amersham) in blocking solution was rocked for 1 h at room temperature. The antibody was 
poured off and the membrane was washed as stated above. The membrane was exposed to ECL 
solution (Thermo Scientific) and visualized using Bio-Rad Gel/Chemi Doc.  
 
CopZ Copper Loading: A copper loading/binding experiment was performed to determine if 
CopZ mutants could be loaded stoichiometrically or in 5x excess of copper. Standards were 
made with CuSO4. There were three reactions: copper with no protein, protein with 
stoichiometric copper, and protein with 5x copper. The reaction volume was 100 µl and 
contained 10 µM CopZ with 5 mM ascorbate (freshly prepared) and CuSO4 (10 or 50 µM). The 
negative control had 50 µM CuSO4 with no protein. Reactions were rocked for 10 min at room 
temperature. The loaded protein was passed through 1 ml Sephadex G-25 and eluted with 100 µl 
of water in each of 4 elution fractions. Protein in reactions 3 and 4 were quantified according to 
Bradford (19). Approximately 0.25 nmol protein was added to a new tube. The volume was 
completed to 70 µl with water. TCA (10 µl of 60%) was added and the samples were vortexed. 
Samples were centrifuged at max speed for 5 min and 75 µl of the supernatant was transferred to 
a new tube. Ascorbate (5 µl of 5 mM) and 20 µl of bicinchoninic acid (BCA) solution (500 µM 
13 
 
BCA, 260 mM NaOH, and 190 mM HEPES acid) were added next and vortexed. The absorption 
was read at 360 nm (20). 
 
ATPase Assays: Purified CopZ was loaded with a 2:1 molar ratio of CuSO4 and 10 mM ascorbate 
in water for 10 min at room temperature. ATPase assays were performed in a solution containing 
50 mM Tris (pH 7.5 at RT), 3 mM MgCl2, 3 mM ATP, 0.01% asolectin, 0.01% DDM, 400 mM 
NaCl, 2.5 mM DTT, 2.5 µg purified ΔN,C-CopA, and various concentrations of CopZ. A control 
with Cu-free CopZ was used as a blank for each concentration of CopZ. ATPase activity was 
measured after 10 min incubation at 75°C. Released Pi was determined according to Lanzetta et 
al. (21). ATPase activity of CopZ without metal was subtracted from measured values. Curves of 
ATPase activity vs. donor·Cu
+
 (CopZ) concentrations were fit to v = Vmax[donor·Cu
+
]/([ 
donor·Cu
+
]+K1/2 ). The standard errors for Vmax and K1/2 are asymptotic standard errors reported 
by the fitting software KaleidaGraph (Synergy).  
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Results 
The goal of this project was to study interactions CopZ has with CopA during the process 
of delivering copper. To accomplish this goal, mutants of A. fulgidus CopZ were made and then 
the effect of the mutants on the ATPase activity of A. fulgidus CopA was analyzed.   
 
Homology modeling: The homology modeling of CopZ showed a similar structure to the model 
of the HMA domain of the copper chaperone for H. sapiens superoxide dismutase (Fig. 3). The 
copper coordinating cysteines as well as the alpha helices and beta sheets were in comparable 
locations. An electrostatic model of Ct-CopZ was made to determine the locations of polar 
residues with respect to the conserved cysteine residues (Fig. 4). The polar residues that 
surrounded the cysteines were T148, S154, D173, and Y197. 
  
 
Figure 3. Homology modeling of Ct-CopZ and a crystallized homologue. Figure a. is the HMA domain of the 
copper chaperone for H. sapiens superoxide dismutase, Figure c. is A. fulgidus Ct-CopZ and Figure b. is an 
alignment of the two proteins. The copper coordinating cysteines are in blue (H. sapiens) and tan (A.fulgidus).  
 
a. b. c. 
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CopZ Mutant Cloning: The mutant CopZ PCR product was confirmed by digesting with a unique 
restriction enzyme and running on an agarose gel (Fig. 5). Only 4 of the 5 mutants were obtained 
(T148A, D173A, D173K, and Y197A). Both the full plasmid amplification and the megaprimer 
PCR techniques were tried multiple times to obtain S154A with no success. Macrogen 
sequencing verified that only the intended mutations were in the CopZ mutant DNA (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
DNA      T148A     Y197A       DNA      D173A           DNA           D173K 
Ladder                                  Ladder                Ladder  
 
Digestion:                       -     +         -     +                        -       +                              -         + 
Figure 5. Digestion confirmation of T148A, Y197A, D173A, and D173K. T148A DNA was 
digested with SphI. Y197A DNA was digested with NarI. D173A DNA was digested with 
SmaI. D173K DNA was digested with AflII. 
Figure 4. Electrostatic model of A. 
fulgidus Ct-CopZ. Figure a. shows 
the residues that potentially interact 
with CopA. D173, S154, T148, and 
Y197 are blue, red, magenta, and 
black, respectively. The 
coordinating cysteines are in 
orange. Figure b. shows an 
electrostatic model of Ct-CopZ, 
where red is negatively charged and 
blue is positively charged. The 
points on a. correspond to the 
points on b.  
a. b. 
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Uninduced  
 
5 µg 
Induced 
 
10 µg 
Induced 
 
WT CopZ      CTCACATGCATGGGGTGTGTTAGCGCTGTAAAGGCGGCTCTTGAAGAGGCCGGAGCGAAT 60 
D173A CopZ   CTCACATGCATGGGGTGTGTTAGCGCTGTAAAGGCGGCTCTTGAAGAGGCCGGAGCGAAT 60 
D173K CopZ   CTCACATGCATGGGGTGTGTTAGCGCTGTAAAGGCGGCTCTTGAAGAGGCCGGAGCGAAT 60 
S154A CopZ   CTCACATGCATGGGGTGTGTTGCAGCTGTAAAGGCGGCTCTTGAAGAGGCCGGAGCGAAT 60 
T148A CopZ   CTCGCATGCATGGGGTGTGTTAGCGCTGTAAAGGCGGCTCTTGAAGAGGCCGGAGCGAAT 60 
Y197A CopZ   CTCACATGCATGGGGTGTGTTAGCGCTGTAAAGGCGGCTCTTGAAGAGGCCGGAGCGAAT 60 
                     
                             
WT CopZ      GTTGTTGAAATTGGGCTGGACAGGGCTGTTGTTGAGGTTGACGAGGAAGCGGAGCTGCAG 120 
D173A CopZ   GTTGTTGAAATTGGGCTGGCCCGGGCTGTTGTTGAGGTTGACGAGGAAGCGGAGCTGCAG 120 
D173K CopZ   GTTGTTGAAATTGGGCTTAAGAGGGCTGTTGTTGAGGTTGACGAGGAAGCGGAGCTGCAG 120 
S154A CopZ   GTTGTTGAAATTGGGCTGGACAGGGCTGTTGTTGAGGTTGACGAGGAAGCGGAGCTGCAG 120 
T148A CopZ   GTTGTTGAAATTGGGCTGGACAGGGCTGTTGTTGAGGTTGACGAGGAAGCGGAGCTGCAG 120 
Y197A CopZ   GTTGTTGAAATTGGGCTGGACAGGGCTGTTGTTGAGGTTGACGAGGAAGCGGAGCTGCAG 120 
                 
 
WT CopZ      AAACTCGTTGAGGCTGTTGAGGGAGCAGGTTACTC 155 
D173A CopZ   AAACTCGTTGAGGCTGTTGAGGGAGCAGGTTACTC 155 
D173K CopZ   AAACTCGTTGAGGCTGTTGAGGGAGCAGGTTACTC 155 
S154A CopZ   AAACTCGTTGAGGCTGTTGAGGGAGCAGGTTACTC 155 
T148A CopZ   AAACTCGTTGAGGCTGTTGAGGGAGCAGGTTACTC 155 
Y197A CopZ   AAACTCGTTGAGGCTGTTGAGGGAGCAGGCGCCTC 155 
                 
 
 
 
WT CopZ      LTCMGCVSAVKAALEEAGANVVEIGLDRAVVEVDEEAELQKLVEAVEGAGY 51 
D173A CopZ   LTCMGCVSAVKAALEEAGANVVEIGLARAVVEVDEEAELQKLVEAVEGAGY 51 
D173K CopZ   LTCMGCVSAVKAALEEAGANVVEIGLKRAVVEVDEEAELQKLVEAVEGAGY 51 
S154A CopZ   LTCMGCVAAVKAALEEAGANVVEIGLDRAVVEVDEEAELQKLVEAVEGAGY 51 
T148A CopZ   LACMGCVSAVKAALEEAGANVVEIGLDRAVVEVDEEAELQKLVEAVEGAGY 51 
Y197A CopZ   LTCMGCVSAVKAALEEAGANVVEIGLDRAVVEVDEEAELQKLVEAVEGAGA 51 
            
Figure 6. Alignments of WT and mutant CopZ. Figure a. shows the alignment of the section of CopZ cDNA that 
was mutated. Figure b. shows the alignment of the section of CopZ protein that result from the DNA mutations. 
Mutations in the sequences are shown in red.  
 
 
 
 
 
 
 
 
Figure 7. Expression of CopZ mutants. Dot immunoblots of 5 and 10 µg of each protein are shown. 
 
D173A               D173K                  T148A               Y197A 
a. 
b. 
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CopZ Expression: Aliquots of induced and uninduced mutant CopZ cultures were blotted onto a 
nitrocellulose membrane. The His tag on CopZ allowed the membrane to be developed using 
anti-His antibodies with horseradish peroxidase. The dot blot (Fig. 7) showed that all of the 
mutants were expressing CopZ. 
 
Purified CopZ: Wild type and mutant CopZ 
proteins were purified using a Ni-NTA column. 
Only D173A and D173K mutants were able to 
be purified in a large quantity. The S154A and 
T148A mutants were lost after passing through 
the Ni-NTA column. The purified protein was run on a polyacrylamide gel to check for purity 
(Fig. 8). The approximate yield of each protein was 7 mg/l for WT CopZ, 4.3 mg/l for D173A 
CopZ, and 3.6 mg/l for D173K CopZ. 
 
Loading CopZ with Copper: The copper loading experiment was performed to show that WT 
CopZ bound 2 Cu
+
 ions when loaded stoichiometrically. This 
experiment confirmed previous results (7). Once CopZ was shown to 
bind stoichiometrically, the protein did not need to be passed through a 
sephadex column to remove the excess copper (Data not shown).  
 
Purification of ΔN,C-CopA: ΔN,C-CopA was purified using a Ni-
NTA column. The purified protein (15 µg) was run on a 
polyacrylamide gel to check for purity (Fig. 9). The protein was overloaded, which gives the 
appearance of impurities in the sample. The approximate yield for ΔN,C CopA was 1 mg/l.  
      
        CopZ (29.8 kDa) 
 
20 kDa 
1       2      3      4 
Figure 8. Purified CopZ. Lane 1 is the 
protein ladder. Lane 2 is WT CopZ. Lane 3 
is D173A CopZ. Lane 4 is D173K CopZ. 
30 kDa 
Figure 9. Purified ΔN,C-CopA. 
Lane 1 is a protein ladder and 
Lane 2 is purified ΔN,C-CopA. 
     1    2 
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ΔN,C-CopA ATPase Activity: The ATPase assays were performed to determine if there were any 
significant changes in CopZ delivery to ΔN,C-CopA when the potential docking residues were 
altered. First, an experiment to check for differences between the WT and mutant CopZ with 
respect to the Vmax were performed. When compared to WT CopZ protein, the D173A and 
D173K mutants did not make any noticeable differences to the ΔN,C-CopA Vmax (Table 3). 
 
         Table 3. Activities of ATPase assays with various  
                                                    forms of 5 µM copper.¹ n = 3, ² n = 2 
 
 
Activity (nmol * µg
-1
 * h
-1
) 
CopA + Free Cu¹ 2.08 ± 0.33 
WT CopZ¹ 4.79 ± 0.49 
D173A CopZ¹ 4.79 ± 0.79 
D173K CopZ² 4.49 ± 0.43 
 
An alteration in the interaction of CopA with CopZ could also result in reduced affinity, which 
would be indicated by a reduction in the K½ of the overall catalytic process. In order to address 
this possibility, additional experiments were done to determine if there was any difference in the 
K½ of ΔN,C-CopA when compared to WT CopZ. Initially, the concentrations of CopZ added 
were 0.5, 1.25, 2.5 and 5 µM. At this concentration, the resolution of the K½ was low, so 
additional points with lower concentrations of CopZ were added. These were 0.05, 0.125, and 
0.25 µM. The Vmax of either mutant of CopZ was slightly lower than that of WT CopZ (Fig. 10). 
The K½ of the D173K mutant was slightly lower than the wild type.  
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Figure 10. ATPase activity vs. CopZ concentration. The red circles are WT CopZ, the blue squares are 
D173A CopZ, and the green triangles are D173K CopZ.  
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Discussion 
 The homology modeling between the HMA domain of H. sapiens superoxide dismutase 
and A. fulgidus CopZ showed that their structures are very similar. The positions of A. fulgidus 
residues can be trusted because key features of the two proteins such as the coordinating 
cysteines and the alpha helices and beta sheets have the similar locations. This allowed the 
identification of potential polar residues that dock to CopA during copper delivery. 
Not being able to obtain the S154A CopZ mutant was one setback of this project. They 
multiple PCRs were performed with different procedures to try to get a viable mutation. One 
problem that this specific mutation may have had was that the primer was not well designed. If 
this were the case, the primer would not bind to the template with high affinity, leading to no 
amplification. 
 Purifying the CopZ mutants was another hinderance. Although the dot blot showed that 
all the mutants were expressing properly, after passing T148A and Y197A through the Ni-NTA 
resin, the protein was lost. This may be because somewhere in the purification the His tag or 
another part of the protein gets cleaved.  
There was no change in the Vmax of ΔN,C-CopA ATPase activity when potential docking 
sites of CopZ are changed. This suggests that the mutation did not affect the rate limiting step of 
the enzyme. Another alternative explanation is that having only one site mutated is not enough to 
alter the delivery affinity. Since there are potentially 4 sites, maybe more than one site have to be 
mutated to see a significant change. That is, each site docks strong enough to overcome the loss 
of one single site. Another hypothesis is that there are other sites that help CopZ dock to CopA 
either near the copper coordinating cysteines or on the sides which would allow interactions with 
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the other regions. These would make any single mutation less severe because there are redundant 
docking sites.  
The ATPase concentration curves had a good fit. There was one point in WT and D173A 
CopZ that did not fit the curve. This may be due to pipetting error. The K½ of D173K CopZ was 
about half that of WT and D173K. The Vmax of the mutants were slightly lower in the plots than 
when doing the Vmax alone. When considering the error in the plot, neither of these differences 
may be significant.  
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